Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-20-138677
Filing Date
2020-12-23
Accepted
2020-12-22 18:01:11
Documents
5

Document Format Files

Seq Description Document Type Size
1 424B5 tm2039170d1_424b5.htm 424B5 413257
2 GRAPHIC image_001.jpg GRAPHIC 4365
3 GRAPHIC image_002.jpg GRAPHIC 4363
4 GRAPHIC tm2027047d1_s3img001.jpg GRAPHIC 29328
5 GRAPHIC tm2027047d1_s3img002.jpg GRAPHIC 10026
  Complete submission text file 0001104659-20-138677.txt   481215
Mailing Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 (608) 441-8120
Cellectar Biosciences, Inc. (Filer) CIK: 0001279704 (see all company filings)

IRS No.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-244362 | Film No.: 201409196
SIC: 2834 Pharmaceutical Preparations